Azaspirooctane-carboxylates as Novel Activators/Modulators of M4 for the Treatment of Alzheimer’s Disease and Parkinson’s Disease

IF 3.5 3区医学 Q2 CHEMISTRY, MEDICINAL

ACS Medicinal Chemistry Letters Pub Date : 2024-11-04 DOI:10.1021/acsmedchemlett.4c0051210.1021/acsmedchemlett.4c00512

Gerard Rosse*,

引用次数: 0

Abstract

Novel azaspirooctane-carboxylates are described for potential treatment of Alzheimer’s disease and Parkinson’s disease, among other conditions.

查看原文本刊更多论文

作为治疗阿尔茨海默病和帕金森病的新型 M4 激活剂/调节剂的氮杂环辛烷羧酸盐

介绍了新型氮杂螺辛烷羧酸盐用于治疗阿尔茨海默病和帕金森病等疾病的可能性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

ACS Medicinal Chemistry Letters CHEMISTRY, MEDICINAL-

CiteScore

7.30

自引率

2.40%

发文量

328

审稿时长

1 months

期刊介绍： ACS Medicinal Chemistry Letters is interested in receiving manuscripts that discuss various aspects of medicinal chemistry. The journal will publish studies that pertain to a broad range of subject matter, including compound design and optimization, biological evaluation, drug delivery, imaging agents, and pharmacology of both small and large bioactive molecules. Specific areas include but are not limited to: Identification, synthesis, and optimization of lead biologically active molecules and drugs (small molecules and biologics) Biological characterization of new molecular entities in the context of drug discovery Computational, cheminformatics, and structural studies for the identification or SAR analysis of bioactive molecules, ligands and their targets, etc. Novel and improved methodologies, including radiation biochemistry, with broad application to medicinal chemistry Discovery technologies for biologically active molecules from both synthetic and natural (plant and other) sources Pharmacokinetic/pharmacodynamic studies that address mechanisms underlying drug disposition and response Pharmacogenetic and pharmacogenomic studies used to enhance drug design and the translation of medicinal chemistry into the clinic Mechanistic drug metabolism and regulation of metabolic enzyme gene expression Chemistry patents relevant to the medicinal chemistry field.